Swiss Scientists Create Wireless Implant to Monitor Blood Sugar, Heart Problems, and More in Real Time

Scientists at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have recently developed a new medical implant device that works with a person’s smartphone or tablet to relay medical conditions to its receiver. The 14 millimeter device can detect a variety of chemical levels in the blood and warn its user or a doctor of possible medical problems—from high blood sugar levels in a diabetes patient to indicators of an impending heart attack. (In the case of a heart attack, a protein known as troponin is released into the bloodstream hours before a heart attack occurs. EPFL’s medical implant is potentially able to detect this.)

Once implanted under a person’s skin, the device is powered by a process known as wireless inductive charging, and it transmits data via Bluetooth to a patient’s smartphone or tablet device. Once the data is on the patient’s smartphone or tablet, software can monitor the data, trigger an alarm, or message a patient’s doctor.

Although the device is initially being considered for monitoring medical conditions related to heart disease, diabetes, and cancer, other possible applications include monitoring the conditions of athletes, women in pregnancy, explorers in extreme conditions, and soldiers in action.

Congratulations—and thank you—to the scientists at EPFL for developing this life-serving technology.


Image: EPFL

Return to Top

Comments submitted to TOS are moderated and checked periodically. Commenters must use their real names, and comments may not exceed 400 words. For a comment to be approved, it must be civil, substantive, and on topic. Ad hominem attacks, arguments from intimidation, misrepresentations, unsubstantiated accusations, baseless assertions, and comments that ignore relevant points made in the article are not permitted. Comments that violate these rules will not be approved. Thank you for helping us to keep the discussion intellectually profitable.

No comments yet.

Leave a Reply